Dependabot/npm and yarn/npm and yarn b86496a78e (#209)

## Description
<!-- Briefly describe what this PR adds or changes. -->

## Type of Change
- [x] 🆕 New prompt addition
- [x] 🔧 Prompt improvement/fix
- [x] 🎨 UI component (React/Tailwind)
- [x] 🧪 Feature implementation
- [x] 📋 Documentation update
- [x] 🗂️ Category organization
- [x] 🐛 Bug fix
- [x] 🔒 Security fix
- [x] Other: ___________

## Category
<!-- Which category does this affect? -->
- [x] ui-design
- [x] web-development
- [x] components
- [x] ux-research
- [x] animation
- [x] responsive
- [x] accessibility
- [x] src/ (codebase change)
- [x] supabase/ (backend change)

## Brand Alignment (for UI/component changes)
<!-- Does this change maintain the "Clinical Luxury" brand DNA? -->
- [x] Uses Soft Ivory (#F8F8FF) as the background canvas
- [x] Uses Deep Maroon (#800020) for primary actions and headers
- [x] Uses Shiny Gold (#C5A028) for 1px borders and hover states (the
"Gold Stitch")
- [x] Uses Dark Charcoal (#333333) for body text
- [x] Supports RTL layout for Arabic localization
- [x] N/A — no visual changes

## Checklist

### For New Prompts
- [x] Prompt follows the established format (YAML frontmatter +
sections)
- [x] Includes clear description
- [x] Contains example usage
- [x] Provides sample output (if applicable)
- [x] Has appropriate tags
- [x] Tested with Claude
- [x] Placed in correct category directory
- [x] Frontend-focused content

### For Code Changes
- [x] `npm run lint` passes with 0 errors
- [x] `npm run build` completes without errors
- [x] RTL (Arabic) layout is not broken
- [x] Mobile responsive on all breakpoints
- [x] Tailwind uses semantic tokens (not raw hex values)

### For All Contributions
- [x] Clear and understandable content
- [x] No spelling or grammar errors
- [x] Follows contribution guidelines
- [x] No duplicate content
- [x] No sensitive credentials or API keys committed

## Testing
- [x] I have tested this locally
- [x] The changes produce consistent, expected results
- [x] The examples work as described (for prompts)
- [ ] Verified on mobile viewport

## Additional Notes
<!-- Add any additional context, screenshots, or information about your
changes here. -->

<!-- closes #[issue-number] -->

Author: asperpharma